Pharmacy, pharmaceuticals and public policy : Solving the puzzle
Copyright © 2019 Elsevier Inc. All rights reserved..
Increasing pressure on healthcare demand and delivery has resulted in the development of new roles and services for pharmacists. As current models of pharmacy practice continue to be evaluated, pharmacists must be involved in identifying new areas that may require research. In order to do so, the current vision of the future of pharmacy practice is discussed in this commentary. Issues such as adequate funding, professional competency and building strong interprofessional relationships are still identified as major barriers to change. These barriers have been grouped into the themes that form a conceptual model of the factors affecting the future of pharmacy practice, which have led to the development of key questions for the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Research in social & administrative pharmacy : RSAP - 16(2020), 6 vom: 02. Juni, Seite 840-843 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nagaria, Raveena Amee [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Future |
|---|
| Anmerkungen: |
Date Completed 28.07.2021 Date Revised 28.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.sapharm.2019.07.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM299634655 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM299634655 | ||
| 003 | DE-627 | ||
| 005 | 20231225100748.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.sapharm.2019.07.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0998.xml |
| 035 | |a (DE-627)NLM299634655 | ||
| 035 | |a (NLM)31351779 | ||
| 035 | |a (PII)S1551-7411(19)30400-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nagaria, Raveena Amee |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacy, pharmaceuticals and public policy |b Solving the puzzle |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.07.2021 | ||
| 500 | |a Date Revised 28.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier Inc. All rights reserved. | ||
| 520 | |a Increasing pressure on healthcare demand and delivery has resulted in the development of new roles and services for pharmacists. As current models of pharmacy practice continue to be evaluated, pharmacists must be involved in identifying new areas that may require research. In order to do so, the current vision of the future of pharmacy practice is discussed in this commentary. Issues such as adequate funding, professional competency and building strong interprofessional relationships are still identified as major barriers to change. These barriers have been grouped into the themes that form a conceptual model of the factors affecting the future of pharmacy practice, which have led to the development of key questions for the future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Future | |
| 650 | 4 | |a Health policy | |
| 650 | 4 | |a Pharmaceutical policy | |
| 650 | 4 | |a Pharmacy practice | |
| 650 | 4 | |a Pharmacy practice research | |
| 650 | 4 | |a Public policy | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 700 | 1 | |a Hasan, Syed Shahzad |e verfasserin |4 aut | |
| 700 | 1 | |a Babar, Zaheer-Ud-Din |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Research in social & administrative pharmacy : RSAP |d 2005 |g 16(2020), 6 vom: 02. Juni, Seite 840-843 |w (DE-627)NLM166902047 |x 1934-8150 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2020 |g number:6 |g day:02 |g month:06 |g pages:840-843 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.sapharm.2019.07.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2020 |e 6 |b 02 |c 06 |h 840-843 | ||